Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOD-4023 Dose Finding in Adult Growth Hormone Deficiency
NCT01225666Phase 2Completed
- Sponsor
- OPKO Health
- Start
- Aug 2010
- Primary completion
- Jul 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 6
01
Overview
A Phase 2 trial of somatrogon in growth hormone deficiency (GHD), sponsored by OPKO Health. Started Aug 2010; status: completed.
02
Drugs
somatrogon
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01225666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01225666.